You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction
Free

https://doi.org/10.1136/heartjnl-2013-305399corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Pilgrim T, Windecker S. Antiplatelet therapy for secondary prevention of coronary artery disease. Heart 2014;100:1750–56. doi:10.1136/heartjnl-2013-305399corr1

    In this paper the below paragraph contains 2 dosage errors.

    ‘According to the guidelines on myocardial revascularisation by the European Society of Cardiology DAPT with aspirin (75–100 mg four times a day) (IB) and clopidogrel (75 mg four times a day) (IA) in the setting of stable CAD is recommended for at least 1 month in patients treated with BMS and for 6–12 months in patients after DES implantation’.

    Both dosages should be prescribed daily and not four times a day as stated in the published version.

    View Abstract

    Linked Articles